Patient Recruitment/Retention Featured Articles
-
Understanding Precision Neuroscience As Treatment For Rare Autoantibody Disease
1/19/2024
J&J Innovative Medicine develops precision therapeutics in neuroscience, reducing the trial participation and treatment burdens on people living with generalized myasthenia gravis.
-
Patient Engagement Needs More Benefit Analysis, Fewer Theoretical Conversations
1/12/2024
Are companies just tagging on to the status quo of being “patient-centric” without fully analyzing the return on investment for their company? Consultant and patient advocate Ella Balasa discusses.
-
Why We Need More Women In Clinical Research — Now
1/10/2024
Society’s tendency to view the male body as “default” has had relatively benign, if not uncomfortable, effects. But, gender bias can have serious consequences, including in clinical research.
-
What Rare Disease Patients Want Sponsors To Know
1/9/2024
A rare disease caregiver and patient, Sabina Kineen hopes to shine a light on the importance of clinical trial education for patients and caregivers and how sponsors can support them.
-
What Experts Think Will Happen With Patient Centricity In 2024
12/27/2023
In part two, experts discuss patient centricity themes, including diversity, equity, and inclusion (DEI) and precision medicine, in the clinical trials industry as we move into 2024.
-
When A Rare Disease Partnership Evolves Into A Global Effort
12/21/2023
Marked by a gradual evolution from small, meeting-oriented work to a transformative initiative, the FSHD Society and Fulcrum Therapeutics partnership in rare disease research exemplifies the power of trust and shared commitment.
-
Two Sponsors And A Site Expert Walk Into A DCT Discussion
12/15/2023
Do DCTs live up to the hype? Three experts discuss new technologies, FDA regulations, and whether DCTs are making life easier or harder for patients and sites.
-
An Overview Of Patient Service Programs Technology
12/15/2023
Discover all the applicable technologies aimed at improving patient adherence, patient access, patient affordability, and patient advocacy.
-
New Calculator Could Help Trial Participants And Sponsors Determine Costs And Fair Compensation
12/14/2023
Try the industry’s first open access financial burden calculator to help patients, sponsors, and other stakeholders estimate the cost burden patients may face.
-
Can Data Help Improve Diversity In Clinical Trials?
12/7/2023
Denise Bronner Ph.D., director of diversity, equity, and inclusion in clinical trials at Johnson & Johnson Innovative Medicine (JJIM) talks about some of the types of datasets that can be leveraged to improve diversity in clinical trials.